Cargando…

Lipocalin-2 in Fructose-Induced Fatty Liver Disease

The intake of excess dietary fructose most often leads to non-alcoholic fatty liver disease (NAFLD). Fructose is metabolized mainly in the liver and its chronic consumption results in lipogenic gene expression in this organ. However, precisely how fructose is involved in NAFLD progression is still n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambertz, Jessica, Berger, Thorsten, Mak, Tak W., van Helden, Josef, Weiskirchen, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712346/ https://www.ncbi.nlm.nih.gov/pubmed/29234288 http://dx.doi.org/10.3389/fphys.2017.00964

Ejemplares similares

Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
por: Lambertz, Jessica, et al.
Publicado: (2017)

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016)

Quantification of Short Chain Fatty Acids (acetate, butyrate, propionate) in human blood with ion exclusion chromatography
por: Bertges, Markus, et al.
Publicado: (2021)

Tear Lipocalin and Lipocalin-Interacting Membrane Receptor
por: Glasgow, Ben J.
Publicado: (2021)

Editorial: Liver Myofibroblasts
por: Kanta, Jiri, et al.
Publicado: (2016)

Lipocalin 2 receptors: facts, fictions, and myths
por: Schröder, Sarah K., et al.
Publicado: (2023)

Depletion of Lipocalin 2 (LCN2) in Mice Leads to Dysbiosis and Persistent Colonization with Segmented Filamentous Bacteria
por: Klüber, Patrick, et al.
Publicado: (2021)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Glucose versus fructose metabolism in the liver measured with deuterium metabolic imaging
por: Hendriks, Arjan D., et al.
Publicado: (2023)

Phosphofructokinase-1 and fructose bisphosphatase-1 in canine liver and kidney
por: KANAI, Shuichiro, et al.
Publicado: (2019)

Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid–induced HepG2 cells and high-fat/high-fructose diet-fed mice
por: Park, Miey, et al.
Publicado: (2020)

Data on IL-10R neutralization-induced chronic colitis in Lipocalin 2 deficient mice on BALB/c background
por: Singh, Vishal, et al.
Publicado: (2017)

Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
por: Jin, Ran, et al.
Publicado: (2014)

An Evolutionary Perspective of the Lipocalin Protein Family
por: Diez-Hermano, Sergio, et al.
Publicado: (2021)

Hypoxia Induces Astrocyte-Derived Lipocalin-2 in Ischemic Stroke
por: Ranjbar Taklimie, Fatemeh, et al.
Publicado: (2019)

The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
por: Weiskirchen, Ralf, et al.
Publicado: (2015)

The biotin interference within interference suppressed immunoassays
por: Kabiri, Payam, et al.
Publicado: (2021)

Into the Labyrinth of the Lipocalin α1-Acid Glycoprotein
por: Ruiz, Mario
Publicado: (2021)

Editorial: Functional Profile of the Lipocalin Protein Family
por: Ganfornina, Maria Dolores, et al.
Publicado: (2022)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Deletion of Perilipin 5 Protects against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation
por: Asimakopoulou, Anastasia, et al.
Publicado: (2020)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

The AMPK pathway in fatty liver disease
por: Fang, Chunqiu, et al.
Publicado: (2022)

Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D(2) Synthase as a Multifunctional Lipocalin
por: Urade, Yoshihiro
Publicado: (2021)

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
por: Chen, Qian, et al.
Publicado: (2017)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Biological Roles of Lipocalins in Chemical Communication, Reproduction, and Regulation of Microbiota
por: Stopková, Romana, et al.
Publicado: (2021)

The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review
por: Sanchez, Diego, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)

Effects of maternal fructose intake on the offspring’s kidneys
por: Argeri, Rogério, et al.
Publicado: (2022)

N-Glycosylation of Lipocalin 2 Is Not Required for Secretion or Exosome Targeting
por: Borkham-Kamphorst, Erawan, et al.
Publicado: (2018)

Wilson disease — the impact of hyperimmunity on disease activity: A case report
por: Stremmel, Wolfgang, et al.
Publicado: (2021)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma
por: Asimakopoulou, Anastasia, et al.
Publicado: (2019)

Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond
por: Bhusal, Anup, et al.
Publicado: (2021)

Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart
por: Bošković, Maja, et al.
Publicado: (2022)

Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes
por: Xu, Yanyong, et al.
Publicado: (2019)

Lipocalin 2 Regulates Inflammation during Pulmonary Mycobacterial Infections
por: Guglani, Lokesh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d4kcm04nn2u4tlhjgpdt15fu2a